OR4X1 Antibody

Frequently Asked Questions

What is OR4X1 and why is it studied using antibody-based methods?

OR4X1 (olfactory receptor 4X1, also known as olfactory receptor OR11-104) belongs to the olfactory receptor family 4, subfamily X, member 1. It is part of the G-protein-coupled receptor (GPCR) family involved in olfactory signaling pathways . These receptors interact with odorant molecules in the nose to initiate neuronal responses that trigger smell perception. As a member of the GPCR family with a characteristic 7-transmembrane domain structure, OR4X1 is studied using antibody-based methods to investigate its expression, localization, and function in olfactory and potentially non-olfactory tissues . Antibody-based detection methods provide spatial resolution and sensitivity needed to study this receptor's distribution and expression levels.

What applications are OR4X1 antibodies validated for?

Based on available commercial antibodies, OR4X1 antibodies are primarily validated for:

Most available antibodies are rabbit polyclonal antibodies that react with human OR4X1 . The specific applications should be verified for each individual antibody product as validation can vary between manufacturers.

How should OR4X1 antibodies be stored and handled for optimal performance?

OR4X1 antibodies are typically supplied in liquid form in PBS buffer containing 50% glycerol, 0.02% sodium azide, and sometimes other stabilizers like BSA . For optimal performance:

• Store at -20°C or -80°C upon receipt

• Avoid repeated freeze-thaw cycles by making small aliquots

• When thawed for use, store at 4°C for short-term (1-2 weeks) usage

• Return to -20°C for long-term storage

• Some suppliers recommend avoiding more than 5 freeze-thaw cycles

The high glycerol content (50%) in the storage buffer prevents damaging ice crystal formation during freezing and thawing cycles, maintaining antibody integrity.

What controls should be included when using OR4X1 antibodies in Western blot experiments?

When designing Western blot experiments with OR4X1 antibodies, include the following controls:

• Positive control: Tissue or cell lysate known to express OR4X1 (typically from nasal epithelium or specific neuronal tissues)

• Negative control: Tissue or cells known not to express OR4X1

• Blocking peptide control: Run parallel blots with antibody pre-incubated with blocking peptide (several suppliers offer matching OR4X1 blocking peptides)

• Loading control: Use housekeeping proteins (β-actin, GAPDH) to normalize protein loading

• Antibody specificity control: Secondary antibody-only condition to detect non-specific binding

For proteins with low expression levels like olfactory receptors, enrichment techniques may be necessary before Western blot detection .

What sample preparation methods are optimal for detecting OR4X1 in immunofluorescence experiments?

For optimal detection of OR4X1 in immunofluorescence experiments:

• Fixation: 4% paraformaldehyde (PFA) for 15-20 minutes at room temperature is typically recommended

• Permeabilization: 0.1-0.3% Triton X-100 in PBS for 10 minutes (critical for accessing the intracellular domains of this transmembrane protein)

• Blocking: 5-10% normal serum (matching the species of secondary antibody) with 1% BSA in PBS for 1 hour

• Antibody incubation: Primary antibody diluted 1:100-1:500 in blocking buffer; incubate overnight at 4°C

• Detection: Fluorophore-conjugated secondary antibody (anti-rabbit) diluted according to manufacturer's recommendations

Since OR4X1 is a transmembrane protein, membrane preservation during sample preparation is crucial for accurate localization studies.

How can non-specific binding be minimized when using OR4X1 antibodies?

Non-specific binding is a common challenge with antibodies targeting olfactory receptors. To minimize this issue:

• Optimize antibody concentration: Titrate the antibody to find the minimum concentration that gives specific signal

• Improve blocking: Use 5% milk or 5% BSA in TBST for Western blots; for IF/ICC, include 0.1-0.3% Triton X-100 in blocking buffer

• Increase washing stringency: Use 0.1% Tween-20 in PBS/TBS and increase washing steps (5-6 washes, 5 minutes each)

• Pre-adsorb antibody: Incubate diluted antibody with tissues/cells known not to express OR4X1

• Use blocking peptide: Confirm specificity by comparing with antibody pre-incubated with specific blocking peptide

• Optimize fixation protocol: Over-fixation can increase background, while under-fixation can reduce specific signal

Careful optimization of these parameters can significantly improve signal-to-noise ratio in OR4X1 detection.

What are the major challenges in detecting OR4X1 protein expression, and how can they be addressed?

Major challenges in detecting OR4X1 include:

Additionally, using recombinant expression systems as positive controls can provide valuable reference points for validating detection methods .

How can OR4X1 antibodies be employed in co-immunoprecipitation studies to identify interaction partners?

For co-immunoprecipitation (co-IP) studies with OR4X1:

• Cell lysis optimization: Use mild detergents (0.5-1% NP-40, 0.5% Triton X-100) to solubilize membrane proteins while preserving protein-protein interactions

• Pre-clearing: Incubate lysate with protein A/G beads to remove non-specific binding proteins

• Antibody immobilization: Covalently cross-link OR4X1 antibody to protein A/G beads using BS3 or DMP to prevent antibody co-elution

• Immunoprecipitation: Incubate pre-cleared lysate with antibody-conjugated beads overnight at 4°C with gentle rotation

• Washing: Use increasingly stringent wash buffers to remove non-specific interactions

• Elution: Use gentle elution with peptide competition or more stringent elution with low pH glycine buffer

• Analysis: Identify interacting partners using mass spectrometry or Western blot for suspected partners

When working with GPCRs like OR4X1, consider using MYTH (membrane yeast two-hybrid) or MYTH-based co-IP systems specifically designed for membrane protein interactions .

What considerations should be taken when designing experiments using OR4X1 antibodies for tissue microarray applications?

When using OR4X1 antibodies for tissue microarray (TMA) applications:

• Antibody validation: Extensively validate antibody specificity on known positive and negative controls before TMA application

• Antigen retrieval optimization: Test multiple methods (heat-induced, enzymatic) to determine optimal epitope exposure

• Signal amplification: Consider using tyramide signal amplification or polymer detection systems to enhance sensitivity

• Multiplex staining: For co-localization studies, carefully select compatible antibodies raised in different host species

• Automated analysis: Develop robust image analysis protocols with appropriate controls for quantification

• Controls on TMA: Include control tissues directly on the TMA slide to account for staining variability

• Normalization strategies: As described in antibody microarray literature, apply appropriate normalization methods to correct for systematic biases in signal intensity

These considerations align with established protocols for antibody microarrays while addressing the specific challenges of detecting membrane proteins like OR4X1 .

How can out-of-distribution prediction models improve OR4X1 antibody development and characterization?

Recent research in antibody-antigen binding prediction indicates that:

• Library-on-library approaches: When many antigens are probed against many antibodies, machine learning models can predict binding relationships

• Out-of-distribution challenges: Models struggle when test antibodies and antigens aren't represented in training data

• Active learning strategies: Can reduce experimental costs by starting with small labeled data subsets and iteratively expanding

• Efficiency improvements: The best algorithms can reduce required antigen mutant variants by up to 35% and accelerate learning by 28 steps compared to random approaches

These advanced computational approaches can be applied to OR4X1 antibody development to:

• Predict cross-reactivity with other olfactory receptors

• Optimize epitope selection for new antibodies

• Estimate binding affinity for different applications

• Reduce experimental validation requirements

What methods can be used to validate the specificity of OR4X1 antibodies?

Comprehensive validation of OR4X1 antibody specificity should include:

• Peptide competition assay: Pre-incubate antibody with immunizing peptide to block specific binding

• Knockout/knockdown controls: Compare staining patterns in OR4X1 knockout or siRNA knockdown samples versus wild-type

• Recombinant expression: Test antibody on cells overexpressing tagged OR4X1 protein

• Orthogonal detection: Confirm results using alternative methods (e.g., RT-PCR, in situ hybridization)

• Cross-reactivity testing: Test against closely related olfactory receptors to ensure specificity

• Multiple antibodies comparison: Use antibodies targeting different epitopes of OR4X1

• Mass spectrometry verification: Confirm identity of immunoprecipitated protein bands

Given the high sequence similarity among olfactory receptors, rigorous specificity validation is particularly important for OR4X1 antibodies .

What are the recommended dilution ranges and incubation conditions for OR4X1 antibodies across different applications?

Note that these ranges represent general guidelines from available products . Optimal dilutions should be determined empirically for each specific application and sample type. For membrane proteins like OR4X1, longer incubation times (overnight at 4°C) often yield better results than shorter incubations at room temperature.